Title | Bayer organizational structure 2017 11 30 |
---|---|
Author | Vincent De Clerck |
Course | Maatschappijgeschiedenis van de Hedendaagse Periode |
Institution | Vrije Universiteit Brussel |
Pages | 1 |
File Size | 123.3 KB |
File Type | |
Total Downloads | 30 |
Total Views | 147 |
Download Bayer organizational structure 2017 11 30 PDF
Organization Chart Group Management Board
1
Werner Baumann
Johannes Dietsch 1
Hartmut Klusik*
Kemal Malik
Dieter Weinand
Erica Mann
Liam Condon
Chairman
Finance
Human Resources, Technology and Sustainability
Innovation
Pharmaceuticals
Consumer Health
Crop Science
until May 31, 2018; effective June 1, 2018, Wolfgang Nickl
Pharmaceuticals (D. Weinand) 1
Drug Discovery
A. Busch
Chief Medical Officer
M. Devoy
Development
J. Möller
Finance
J. Triana
Commercial Ops. EMEA
R. Franzen
Commercial Ops. Americas
C. Brunn
Commercial Ops. China & APAC
W. Jiang
Commercial Ops. Japan
H. Prinz
Oncology SBU
R. LaCaze
Product Supply
W. Carius
Strategic Marketing
S. Guth
1
Consumer Health (E. Mann)
Crop Science (L. Condon)
Finance
Agricultural Commercial Ops.
Commercial Ops. North America
O. Mauroy Bressier N. Bartner
Commercial Ops. China
L. Yuen
Commercial Ops. International
J. Ohle
Strategic Marketing
G. Vreeken
Innovation & Development
J. O’Mullane
Product Supply
J. Koelink
Government Affairs
J. Fielding
M. Reichardt
Finance
M. A. Schulz
Product Supply
D. Backhaus
Research & Development
A. Percy
Business Affairs & Communications
B. Naaf
Crop Strategies & Portfolio Management M. Kremer Digital Farming
T. Menne
Environmental Science
J. Applegate
Pre-Merger Planning
F. Terhorst
Post Merger Integration
M. Dawkins
Animal Health (D. Ehle)
until 31.12.2017
Corporate Functions Corporate Office
M. Arnold
Regional Coordination
V. Hahn
Engineering & Technology
Strategy
T.-P. Hausner
Law, Patents & Compliance
G. Harnier
Corporate Health, Safety & Sustainability
K. va n Laak
Investor Relations
O. Maier
Finance
P. Müller
Corporate Techn. & Manufacturing
N.N.
Communications and Public Affairs
M. Preuss
Corporate Controlling
G. Schildmeyer
Bayer Life Science Center
A. Bouchon
Mergers, Licencing & Acquisitions
F. Rittgen
Procurement
T. Udesen
Corporate Innovation and R&D
M. Lessl
Internal Audit
R. Schwarz
Human Resources & Organization
A. Günther
Risk Management
M. Baum
Corporate Quality
P.-G. Heiden
Accounting & Taxes
B.-P. Bier
Corporate Supply Chain
R. Heumann
Business Services Executive Board
Chairman
A. Knors
Currenta Executive Board
D. Hartert W. Oehlschläger*
Chairman
G. Hilken A. Wagner*
Fields of Activity Pharmaceuticals
Consumer Health
Crop Science
Prescription medicines for
· Including over-the-counter medicines, dietary supplements,
· Cardiovascular diseases
dermatology products, foot care products, sunscreens and
Crop Protection · Insecticides, Fungicides, Herbicides, SeedGrowth
· Oncological diseases · Ophthalmology · Women’s Healthcare · Hematology
other non-prescription products · Prescription dermatology products
Environmental Science · Professional Products, Consumer Products Seeds · Vegetable Seeds, Seeds for Agricultural Crops, Traits
· Radiology · Other diseases: multiple sclerosis, infections, erectile dysfunction, testosterone deficiency
Animal Health Products and services for the prevention and treatment of diseases in companion and farm animals
* Labor Director
As of November 30, 2017...